Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
2020 · Signal Transduction and Targeted Therapy · 1,968 citations
https://doi.org/10.1038/s41392-020-00312-6
L
Liangbin Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
2.3K
Citations
6
h-index
6
i10-index
Liangbin Lin is an academic researcher from Third People's Hospital of Chengdu. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Immune Cell Function and Interaction & Immune cells in cancer. The author has an h-index of 6, co-authored 17 publications.
ORCID: 0000-0003-0455-2569Papers by this author
worksSystemic lupus erythematosus: pathogenesis and targeted therapy
2024 · Molecular Biomedicine · 38 citations
https://doi.org/10.1186/s43556-024-00217-8
Identification of EMT-associated prognostic features among grade II/III gliomas
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-53399-0
Author Correction to: TRIM29 negatively controls antiviral immune response through targeting STING for degradation
2018 · Cell Discovery · 3 citations
https://doi.org/10.1038/s41421-018-0031-4
Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas
2024 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-024-62869-4
A novel tumor-progressing fibroblast signature derived from single-cell RNA sequencing enables prognostic stratification and reveals RNF11 as a functional regulator in bladder cancer
2026 · Frontiers in Molecular Biosciences · 0 citations
https://doi.org/10.3389/fmolb.2025.1722809
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat